S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ZoetisVertex PharmaceuticalsBayer AktiengesellschaftGlaxoSmithKlineCSL
SymbolNYSE:ZTSNASDAQ:VRTXOTCMKTS:BAYRYNYSE:GSKOTCMKTS:CSLLY
Price Information
Current Price$155.24$212.55$15.30$33.61$102.64
52 Week RangeBuyBuyHoldHoldHold
MarketRank™
Overall Score2.12.41.01.11.0
Analysis Score1.34.40.00.00.0
Community Score3.23.22.32.02.0
Dividend Score1.70.02.51.71.7
Ownership Score3.31.70.00.00.0
Earnings & Valuation Score1.32.50.01.91.3
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldHold
Consensus Price Target$167.73$291.85N/AN/AN/A
% Upside from Price Target8.04% upside37.31% upsideN/AN/AN/A
Trade Information
Market Cap$73.76 billion$55.25 billion$57.07 billion$84.31 billion$93.40 billion
Beta0.710.791.340.670.59
Average Volume1,942,9902,206,592559,4976,363,26959,124
Sales & Book Value
Annual Revenue$6.26 billion$4.16 billion$48.23 billion$43.10 billion$9.15 billion
Price / Sales11.7813.271.181.9610.21
Cashflow$4.41 per share$4.59 per share$3.36 per share$3.87 per share$2.74 per share
Price / Cash35.1746.274.558.6937.46
Book Value$5.69 per share$23.66 per share$14.27 per share$9.40 per share$7.19 per share
Price / Book27.288.981.073.5814.28
Profitability
Net Income$1.50 billion$1.18 billion$4.58 billion$5.93 billion$2.10 billion
EPS$3.64$4.29$1.77$3.17$2.31
Trailing P/E Ratio46.0726.84N/A10.3444.43
Forward P/E Ratio37.6822.887.9710.9137.19
P/E Growth4.351.256.102.93N/A
Net Margins25.50%38.51%-22.32%18.50%N/A
Return on Equity (ROE)63.89%28.55%14.23%29.60%N/A
Return on Assets (ROA)14.99%20.68%5.01%7.11%N/A
Dividend
Annual Payout$1.00N/A$0.53$2.48$0.97
Dividend Yield0.64%N/A3.46%7.38%0.95%
Three-Year Dividend GrowthN/AN/AN/A-1.26%N/A
Payout Ratio27.47%N/A29.94%78.23%41.99%
Years of Consecutive Dividend Growth1 YearsN/AN/A1 YearsN/A
Debt
Debt-to-Equity Ratio2.41%0.07%1.12%1.13%0.89%
Current Ratio3.47%3.72%1.10%0.90%3.01%
Quick Ratio2.60%3.60%0.81%0.61%1.37%
Ownership Information
Institutional Ownership Percentage92.50%92.17%N/A11.83%0.19%
Insider Ownership Percentage0.17%0.70%N/A10.00%N/A
Miscellaneous
Employees10,6003,000100,61899,43727,000
Shares Outstanding475.17 million259.96 million3.73 billion2.51 billion909.95 million
Next Earnings Date5/5/2021 (Estimated)5/5/2021 (Estimated)N/A5/5/2021 (Estimated)N/A
OptionableOptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.